FDA Approves Human Genome (HGSI) Lupus Treatment Benlysta (GSK)
Go back to FDA Approves Human Genome (HGSI) Lupus Treatment Benlysta (GSK)| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.91 +0.76 (1.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.15 | 52 Week High | $45.58 | |||
| Open | $51.40 | 52 Week Low | $37.82 | |||
| Day High | $51.94 | P/E | N/A | |||
| Day Low | $51.35 | EPS | $0.00 | |||
| Volume | 293,673 | |||||
| Human Genome Sciences, Inc. (NASDAQ: HGSI) | Delayed: 14.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.24 | 52 Week High | $16.58 | |||
| Open | $55.80 | 52 Week Low | $6.51 | |||
| Day High | $14.24 | P/E | N/A | |||
| Day Low | $14.24 | EPS | $-1.79 | |||
| Volume | 557,147 | |||||
